about
Monocytes in atherosclerosis: subsets and functionsA functional heteromeric MIF receptor formed by CD74 and CXCR4MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and SimilaritiesT cells in atherosclerosisMesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shearHydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expressionPRMT5-Mediated Methylation of NF-κB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-α and IFN-γ CostimulationRANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycansMacrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory responseCirculating levels of 8 cytokines and marine n-3 fatty acids and indices of obesity in Japanese, white, and Japanese American middle-aged men.Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.PI3K p110γ deletion attenuates murine atherosclerosis by reducing macrophage proliferation but not polarization or apoptosis in lesions.Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient miceMicrofluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxisMutation in KERA identified by linkage analysis and targeted resequencing in a pedigree with premature atherosclerosis.Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling.μ-Slide Chemotaxis: a new chamber for long-term chemotaxis studies.Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biologyDisruption of SM22 promotes inflammation after artery injury via nuclear factor kappaB activation.Myeloid IκBα deficiency promotes atherogenesis by enhancing leukocyte recruitment to the plaquesEpigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitorsTumor necrosis factor (TNF)-α induction of CXCL10 in endothelial cells requires protein arginine methyltransferase 5 (PRMT5)-mediated nuclear factor (NF)-κB p65 methylation.Impact of age-dependent adventitia inflammation on structural alteration of abdominal aorta in hyperlipidemic mice.RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studiesThe effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels.Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study.CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies.Serum inflammatory cytokines and depression in coronary artery disease.The omega-3 fatty acid docosahexaenoic acid favorably modulates the inflammatory pathways and macrophage polarization within aorta of LDLR(-/-) mice.Genetic engineering of mesenchymal stem cells and its application in human disease therapy.Fractalkine (CX3CL1), a new factor protecting β-cells against TNFαChemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery diseaseReduced levels of microRNAs miR-124a and miR-150 are associated with increased proinflammatory mediator expression in Krüppel-like factor 2 (KLF2)-deficient macrophages(18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markersPET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle.Anxiety, depression, coronary artery disease and diabetes mellitus; an association study in ghaem hospital, iranThe novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levelsGenome-wide association studies in atherosclerosisEffect of folic acid supplementation on levels of circulating Monocyte Chemoattractant Protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectorisAssociation between chemokine receptor 5 (CCR5) delta32 gene variant and atherosclerosis: a meta-analysis of 13 studies.
P2860
Q22251045-573CDA21-14C4-48B3-A988-E3BA2B77E3D5Q24322205-167461C2-29B5-46F1-A7A1-1EBFAFDB2A77Q26800135-E647184C-5121-41E5-8627-9846A5267E54Q27025697-8D6902FD-C10D-43B3-977E-943097BB42C7Q27317423-7726A618-B777-4F47-8ACE-0EB5341781BEQ27332432-5E12D202-D339-4A39-8DDC-FB3D3B38F1C5Q28550383-0F9BFDA9-B571-46F6-8F7B-A46665DDC88CQ28567974-FB099E7F-2A83-49B0-96B3-E5B51303BC7FQ28728841-AFBEEC84-F965-4936-8EFA-A0958F5130B6Q30431623-3D092309-EC9D-4BF7-B8BB-FAB4D56381FDQ30632123-6EC2C099-C5C4-4561-9377-92DEE390FCFDQ31133175-403444D7-9906-41A6-9FA7-2E40B9BEB2BFQ33479145-442A48B5-6444-45A1-9A37-885FEF7A1D34Q33668704-CAF99650-A664-4557-BE18-88631B0F4E42Q33690049-110B7918-7528-42EA-90E1-14148E933A41Q33869955-D127B5AB-0B7F-4C7E-97CC-7634AA5ABBEAQ33904643-4826B6AA-9186-43BA-A3A6-E560D9A4DA33Q33927045-20F0681B-BCD2-4699-8B2A-C06B4300BC0FQ33960960-1CDA7B04-751F-4222-9866-94B9AB4CB389Q33981521-5CF7D5BD-F60F-42D4-A467-4AE7EAB9945FQ34066178-BA260F75-D2B8-47AB-A1D4-9813BD6BCF8BQ34075896-F9B9F551-4B48-4883-8E1B-177473608457Q34083826-8A535877-CF6C-4CFC-8941-B6E00AECD786Q34097785-E4A08754-0DDA-4EC5-9408-55F66040FF7EQ34102994-210F1FAD-B4DF-4CB6-8828-949D839606D3Q34163322-BA0F4BCD-4B7D-44BD-9412-230EED0D4F30Q34193651-13BA9E23-4DED-470F-8668-D3041FA6DCF9Q34197333-2B74482E-A12D-40F6-8EDE-289A268F39B0Q34232750-04E8DECA-D8A5-44D5-90F8-4D0D3ACBE164Q34298871-43CA5559-31AA-4BE5-9F99-4D7DF59FB42DQ34404086-5FF30AC9-B6CF-47C7-95D5-0D6029FB20ACQ34411332-D88D2639-9BD1-428A-9EB3-5866B32820B8Q34467707-C2B10E54-F539-48CC-B5B5-A65D24B9E530Q34506127-C4880E2F-21A3-45D5-BF1A-6506AB872B68Q34632459-FA964392-400D-4539-9CDF-2069AE7582A5Q34733727-E6F19644-FD7E-4C27-8F8E-4FB69CC80FABQ34793225-7FB41D3C-8C28-45D7-8BFD-AF4726237D3FQ34902005-5BF98A80-603A-4CB1-BF2D-420DFA5227BDQ34921979-85E1C5E2-675D-4CA8-AD98-25A6C928AE2DQ35173559-6187F5A1-44D4-424A-A042-9098DB251B69
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Chemokines in atherosclerosis: an update.
@ast
Chemokines in atherosclerosis: an update.
@en
Chemokines in atherosclerosis: an update.
@nl
type
label
Chemokines in atherosclerosis: an update.
@ast
Chemokines in atherosclerosis: an update.
@en
Chemokines in atherosclerosis: an update.
@nl
prefLabel
Chemokines in atherosclerosis: an update.
@ast
Chemokines in atherosclerosis: an update.
@en
Chemokines in atherosclerosis: an update.
@nl
P50
P1476
Chemokines in atherosclerosis: an update.
@en
P304
P356
10.1161/ATVBAHA.107.161174
P407
P577
2008-06-19T00:00:00Z